168 related articles for article (PubMed ID: 28779984)
21. Influence of solid-state acidity on the decomposition of sucrose in amorphous systems. I.
Alkhamis KA
Int J Pharm; 2008 Oct; 362(1-2):74-80. PubMed ID: 18647642
[TBL] [Abstract][Full Text] [Related]
22. Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperatures: implications for freeze-drying.
Shalaev EY; Johnson-Elton TD; Chang L; Pikal MJ
Pharm Res; 2002 Feb; 19(2):195-201. PubMed ID: 11883647
[TBL] [Abstract][Full Text] [Related]
23. Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying.
Martini A; Kume S; Crivellente M; Artico R
PDA J Pharm Sci Technol; 1997; 51(2):62-7. PubMed ID: 9146035
[TBL] [Abstract][Full Text] [Related]
24. Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric beta-galactosidase.
Pikal-Cleland KA; RodrÃguez-Hornedo N; Amidon GL; Carpenter JF
Arch Biochem Biophys; 2000 Dec; 384(2):398-406. PubMed ID: 11368330
[TBL] [Abstract][Full Text] [Related]
25. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation.
Kolhe P; Amend E; Singh SK
Biotechnol Prog; 2010; 26(3):727-33. PubMed ID: 20039442
[TBL] [Abstract][Full Text] [Related]
26. Solute crystallization in frozen systems-use of synchrotron radiation to improve sensitivity.
Varshney DB; Kumar S; Shalaev EY; Kang SW; Gatlin LA; Suryanarayanan R
Pharm Res; 2006 Oct; 23(10):2368-74. PubMed ID: 16927181
[TBL] [Abstract][Full Text] [Related]
27. Mapping of solution components, pH changes, protein stability and the elimination of protein precipitation during freeze-thawing of fibroblast growth factor 20.
Maity H; Karkaria C; Davagnino J
Int J Pharm; 2009 Aug; 378(1-2):122-35. PubMed ID: 19505546
[TBL] [Abstract][Full Text] [Related]
28. Thiol-disulfide exchange in peptides derived from human growth hormone during lyophilization and storage in the solid state.
Chandrasekhar S; Topp EM
J Pharm Sci; 2015 Apr; 104(4):1291-302. PubMed ID: 25631887
[TBL] [Abstract][Full Text] [Related]
29. Characterization of frozen aqueous solutions by low temperature X-ray powder diffractometry.
Cavatur RK; Suryanarayanan R
Pharm Res; 1998 Feb; 15(2):194-9. PubMed ID: 9523303
[TBL] [Abstract][Full Text] [Related]
30. Crystallization of cephalothin sodium during lyophilization from tert-butyl alcohol-water cosolvent system.
Telang C; Suryanarayanan R
Pharm Res; 2005 Jan; 22(1):153-60. PubMed ID: 15771242
[TBL] [Abstract][Full Text] [Related]
31. Phase transitions in frozen systems and during freeze-drying: quantification using synchrotron X-ray diffractometry.
Varshney DB; Sundaramurthi P; Kumar S; Shalaev EY; Kang SW; Gatlin LA; Suryanarayanan R
Pharm Res; 2009 Jul; 26(7):1596-606. PubMed ID: 19326191
[TBL] [Abstract][Full Text] [Related]
32. Stability of ribonuclease A in solution and the freeze-dried state.
Townsend MW; DeLuca PP
J Pharm Sci; 1990 Dec; 79(12):1083-6. PubMed ID: 2079655
[TBL] [Abstract][Full Text] [Related]
33. Quality by design in formulation and process development for a freeze-dried, small molecule parenteral product: a case study.
Mockus LN; Paul TW; Pease NA; Harper NJ; Basu PK; Oslos EA; Sacha GA; Kuu WY; Hardwick LM; Karty JJ; Pikal MJ; Hee E; Khan MA; Nail SL
Pharm Dev Technol; 2011; 16(6):549-76. PubMed ID: 21932931
[TBL] [Abstract][Full Text] [Related]
34. Stability of beta-galactosidase, a model protein drug, is related to water mobility as measured by 17O nuclear magnetic resonance (NMR).
Yoshioka S; Aso Y; Izutsu K; Terao T
Pharm Res; 1993 Jan; 10(1):103-8. PubMed ID: 8430045
[TBL] [Abstract][Full Text] [Related]
35. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
Garidel P; Pevestorf B; Bahrenburg S
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
[TBL] [Abstract][Full Text] [Related]
36. Effect of moisture content on the invertase activity of freeze-dried S. cerevisiae.
Pitombo RN; Spring C; Passos RF; Tonato M; Vitolo M
Cryobiology; 1994 Aug; 31(4):383-92. PubMed ID: 7924395
[TBL] [Abstract][Full Text] [Related]
37. Measurement of the pH of frozen buffer solutions by using pH indicators.
Orii Y; Morita M
J Biochem; 1977 Jan; 81(1):163-8. PubMed ID: 14928
[TBL] [Abstract][Full Text] [Related]
38. Acid-base characteristics of bromophenol blue-citrate buffer systems in the amorphous state.
Li J; Chatterjee K; Medek A; Shalaev E; Zografi G
J Pharm Sci; 2004 Mar; 93(3):697-712. PubMed ID: 14762908
[TBL] [Abstract][Full Text] [Related]
39. Salt formation during freeze-drying--an approach to enhance indomethacin dissolution.
Thakral S; Suryanarayanan R
Pharm Res; 2015 Nov; 32(11):3722-31. PubMed ID: 26063046
[TBL] [Abstract][Full Text] [Related]
40. The effects of formulation additives on the degradation of freeze-dried ribonuclease A.
Townsend MW; Byron PR; DeLuca PP
Pharm Res; 1990 Oct; 7(10):1086-91. PubMed ID: 2126370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
